Latest Insights on ATEN
Gene Editing: The Cure for Every Disease? November 2, 2017 Investment Opportunities If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.No Year-end ‘Window Dressing’ Needed – Our Core Strategy Gains of 2017 October 25, 2017 Wall Street Front Runner Since last month’s update (9/27/17), we closed eight more trades in Wall Street Front Runner. Six “core” trades from the S&P 600: Axcelis Technologies Inc. (NASD: ACLS) … +4.8% NMI Holdings Inc. (NASD: NMIH) … +1.5% Pacific Premier Bancorp Inc. (NASD: PPBI) … +0.0% Photronics Inc. (NASD: PLAB) … -3.7% Par Pacific Holdings Inc. (NYSE: PARR) … -5.3% […]
These 3 IPOs Are a Breath of Fresh Air for Investors October 11, 2017 Investment Opportunities It’s past time to diversify and inject a bit of new blood into your portfolio. Trading IPO stocks can be a risky bet, but it can also be quite rewarding.
How to Profit From Oil Supply and Demand: ETF Charts September 29, 2017 Oil There's good news for oil companies. The headlines lean bullish for oil lately. And there's money to be made in the energy sector right now.
Hate Speech: A Fundamental American Right September 27, 2017 Government & Politics The chief user of free speech (albeit in constant Twitter chatter) is a far greater threat to free speech than anything happening on college campuses.





